MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esbenshade, T. A.
Right arrow Articles by Minneman, K. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esbenshade, T. A.
Right arrow Articles by Minneman, K. P.

Comparison of alpha 1-adrenergic receptor subtypes and signal transduction in SK-N-MC and NB41A3 neuronal cell lines

TA Esbenshade, C Han, TJ Murphy and KP Minneman

Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322.

We compared the alpha 1-adrenergic receptor subtypes in two neuronal cell lines, SK-N-MC (human neuroepithelioma) and NB41A3 (murine neuroblastoma). 125I-BE 2254 labeled alpha 1-adrenergic receptor binding sites in membranes from both cell lines. Pretreatment with the alpha 1B-selective alkylating agent chloroethylclonidine (CEC) completely eliminated these binding sites in NB41A3 cells but caused only a 50% loss in SK-N-MC cells. Displacement with subtype-selective antagonists suggested that NB41A3 cells express only the alpha 1B subtype, whereas SK-N-MC cells express a pharmacologically heterogeneous receptor population, including both alpha 1A and alpha 1B subtypes. Norepinephrine increased [3H] inositol phosphate formation in both cell lines, but with different sensitivities to pertussis toxin and the presence of extracellular Ca2+. CEC pretreatment eliminated this response in NB41A3 cells but caused a maximal 42% reduction in SK- N-MC cells. Use of subtype-selective antagonists showed that the [3H]inositol phosphate response involved only the alpha 1B subtype in NB41A3 cells but a combination of subtypes in SK-N-MC cells. Norepinephrine induced both transient and sustained increases in intracellular Ca2+ concentrations in both cell lines, as measured with fura-2. CEC pretreatment abolished the Ca2+ response in NB41A3 cells but had little effect in SK-N-MC cells. In SK-N-MC cells the Ca2+ response was potently blocked by alpha 1A-selective antagonists. Chelation of extracellular Ca2+ eliminated the sustained component of the Ca2+ signal in both cell lines. Poly(A)+ RNA from NB41A3, DDT1MF-2, BC3H1, and MDCK-D1 cell lines showed one or more prominent transcripts (2.2-4.2 kilobases) that strongly hybridized to the hamster alpha 1B cDNA probe but not to the bovine alpha 1C or rat alpha 1D cDNA probes. Poly(A)+ RNA from SK-N-MC cells showed multiple transcripts (1.3-5.6 kilobases) that hybridized to both hamster alpha 1B and rat alpha 1D but not bovine alpha 1C cDNA probes. We conclude that NB41A3 cells contain exclusively alpha 1B-adrenergic receptors linked to inositol phosphate formation and mobilization of intracellular Ca2+, whereas at least two alpha 1-adrenergic receptor forms, which resemble the alpha 1A and alpha 1B subtypes, coexist in SK-N-MC cells. The CEC-insensitive alpha 1A-like subtype in SK-N-MC cells is capable of increasing inositol phosphate formation and mobilizing intracellular Ca2+.

Volume 44, Issue 1, pp. 76-86, 07/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. M. Finch and R. M. Graham
The {alpha}1D-Adrenergic Receptor: Cinderella or Ugly Stepsister
Mol. Pharmacol., January 1, 2006; 69(1): 1 - 4.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. A. Uberti, R. A. Hall, and K. P. Minneman
Subtype-Specific Dimerization of {alpha}1-Adrenoceptors: Effects on Receptor Expression and Pharmacological Properties
Mol. Pharmacol., December 1, 2003; 64(6): 1379 - 1390.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Lee, A. Robeva, Z. Chen, and K. P. Minneman
Mutational Uncoupling of {alpha}1A-Adrenergic Receptors from G Proteins Also Uncouples Mitogenic and Transcriptional Responses in PC12 Cells
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 471 - 477.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Vicentic, A. Robeva, G. Rogge, M. Uberti, and K. P. Minneman
Biochemistry and Pharmacology of Epitope-Tagged alpha 1-Adrenergic Receptor Subtypes
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 58 - 65.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. D. Pediani, J. F. MacKenzie, R. P. Heeley, C. J. Daly, and J. C. McGrath
Single-Cell Recombinant Pharmacology: Bovine alpha 1a-Adrenoceptors in Rat-1 Fibroblasts Release Intracellular Ca2+, Display Subtype-Characteristic Agonism and Antagonism, and Exhibit an Antagonist-Reversible Inverse Concentration-Response Phase
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 887 - 895.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. J. J. Waugh, R. J. Gaivin, D. S. Damron, P. A. Murray, and D. M. Perez
Binding, Partial Agonism, and Potentiation of alpha 1-Adrenergic Receptor Function by Benzodiazepines: A Potential Site of Allosteric Modulation
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1164 - 1171.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. J. Zuscik, M. T. Piascik, and D. M. Perez
Cloning, Cell-Type Specificity, and Regulatory Function of the Mouse alpha 1B-Adrenergic Receptor Promoter
Mol. Pharmacol., December 1, 1999; 56(6): 1288 - 1297.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Chen, R. Lin, Z.-W. Hu, and B. B. Hoffman
alpha 1-Adrenergic Receptor Activation of c-fos Expression in Transfected Rat-1 Fibroblasts: Role of Ca2+ 
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1376 - 1384.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
A. Berts, H. Zhong, and K. P. Minneman
No Role for Ca++ or Protein Kinase C in Alpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
Mol. Pharmacol., February 1, 1999; 55(2): 296 - 303.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. G. Williams, H. Zhong, and K. P. Minneman
Differential Coupling of alpha 1-, alpha 2-, and beta -Adrenergic Receptors to Mitogen-activated Protein Kinase Pathways and Differentiation in Transfected PC12 Cells
J. Biol. Chem., September 18, 1998; 273(38): 24624 - 24632.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. M. Graham, D. M. Perez, J. Hwa, and M. T. Piascik
{alpha}1-Adrenergic Receptor Subtypes : Molecular Structure, Function, and Signaling
Circ. Res., May 1, 1996; 78(5): 737 - 749.
[Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics